As part of the White House’s Precision Medicine Initiative, the FDA took a new approach in advancing precision medicine by enabling a collaborative community and supporting informatics platform: precisionFDA. Through precisionFDA, FDA is intent on building a strong community contributing toward a standards-based approach for ensuring the accuracy of genetic tests incorporating Next Generation Sequencing (NGS)-based technologies.
